Direct immunosuppressive effects of EBV-encoded latent membrane protein 1

Journal of Immunology

Volumn 165, Issue 2, 2000, Pages 663-670

  Dukers, Danny F ^a,b   Meij, Pauline ^a   Vervoort, Marcel B H J ^a   Vos, Wim ^a   Scheper, Rik J ^a   Meijer, Chris J L M ^a   Bloemena, Elisabeth ^a   Middeldorp, Jaap M ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LATENT MEMBRANE PROTEIN 1; MEMBRANE PROTEIN; VIRUS DNA; VIRUS RNA;

ARTICLE; CENTRIFUGATION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTIC INFILTRATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN PURIFICATION; SEQUENCE HOMOLOGY; T LYMPHOCYTE ACTIVATION;

EID: 0034661694     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.2.663     Document Type: Article

References (36)

1. Pallesen, G., S. J. Hamilton-Dutoit, M. Rowe, and L. S. Young. 1991. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet 337:320.
2. Epstein, M. A., B. G. Achong, and Y. M. Barr. 1964. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1:702.
3. Hamilton-Dutoit, S. J., D. Rea, M. Raphael, K. Sandvej, H. J. Delecluse, C. Gisselbrecht, L. Marelle, H. J. van Krieken, and G. Pallesen. 1993. Epstein-Barr virus latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma: correlation of lymphoma phenotype with three distinct patterns of viral latency. Am. J. Pathol. 143:1072.
4. De Bruin, P. C., N. M. Jiwa, J. J. Oudejans, P. van Heerde, J. C. Sabourin, G. Csanaky, Ph. Gaulard, L. A. Noorduyn, R. Willemze, and C. J. L. M. Meijer. 1993. Presence of Epstein-Barr virus in extranodal T-cell lymphomas: differences in relation to site. Blood 23:509.
5. Klein, G. 1979. The Epstein-Barr Virus. Springer Verlag, Berlin.
6. Weiss, L. M., J. G. Strickler, R. A. Warnke, D. T. Purtilo, and J. Sklar. 1987. Epstein-Barr viral DNA in tissues of Hodgkin's disease. Am. J. Pathol, 129:86,
7. Libetta, C. M., J. H. Pringle, C. A. Angel, A. W. Craft, A. J. Malcolm, and I. Lauder. 1990. Demonstration of Epstein-Barr viral DNA in formalin fixed, paraffin embedded samples of Hodgkin's disease. J. Pathol. 161:255.
8. Wang, D., D, Liebowitz, and E. Kieff. 1985. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43:831.
9. Thorley-Lawson, D. A., and E. S. Israelsohn. 1987. Generation of specific cytotoxic T cells with a fragment of the Epstein-Ban virus-encoded p63/latent membrane protein. Proc. Natl. Acad. Sci. USA 84:5384.
10. Khanna, R., S. R. Burrows, J. Nicholls, and L. M. Poulsen. 1998. Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype-restricted immune recognition of EBV-infected cells by LMP1-specific cytotoxic T lymphocytes. Eur. J. Immunol. 28:451.
11. Rickinson, A. B., D. J. Moss, D. J. Allen, L. E. Wallace, M. Rowe, and M. A. Epstein. 1981. Reactivation of Epstein-Barr virus specific cytotoxic T cells by in vitro stimulation with the autologous lymphoblastoid cell line. Int. J. Cancer 27:593.
12. Meij, P., M. B. H. J. Vervoort, J. Aarbiou, P. van Dissel, A. Brink, E. Bloemena, C. J. L. M. Meijer, and J. M. Middeldorp. 1999. Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases. J. Infect. Dis. 179:1108.
13. Oudejans, J. J., N. M. Jiwa, J. A. Kummer, A. Horstman, W. Vos, J. P. A. Baak, Ph. M. Kluin, P. van der Valk P, J. M. M. Walboomers, and C. J. L. M. Meijer. 1996. Analysis of major histocompatibility complex class I expression on Reed-Stemberg cells in relation to the cytotoxic T-cell response in Epstein-Barr virus positive and negative Hodgkin's disease. Blood 87:3844.
14. Oudejans, J. J., N. M. Jiwa, J. A. Kummer, G. J. Ossenkoppele, P. van Heerde, J. W. Baars, Ph. M. Kluin, J. C. Kluin-Nelemans, P. J. van Diest, J. M. Middeldorp, et al. 1997. Activated cytotoxic T cells as prognostic marker in Hodgkin's disease. Blood 89:1376.
15. Dukers, D. F., E. H. Jaspars, W. Vos, J. J. Oudejans, D. Hayes, S. Cillessen, J. M. Middeldorp, and C. J. L. M. Meijer. Quantitative immunohistochemical analysis of cytokine profiles in Epstein-Barr virus positive and negative cases of Hodgkin's disease. J. Pathol. 190:143.
16. Van den Berg, A., L. Visser, and S. Poppema. 1999. High expression of the CC chemokine TARC in Reed-Sternberg cells: a possible explanation for the characteristic T-cell infiltrate in Hodgkin's lymphoma. Am. J. Pathol. 154:1685.
17. Frisan, T., J. Sjoberg, R. Dolcetti, M. Boiocchi, V. Dere, A. Carbone, C. Brautbar, S. Battat, P. Biberfeld, M. Eckman, et al. 1995. Local suppression of Epstein-Barr virus (EBV)-specific cytotoxicity in biopsies of EBV-positive Hodgkin's Disease. Blood 86:1493.
18. Old, L., and D. A. Clarke. 1959. Reticulo-endothelial function in mice infected with Friend leukemia virus. Fed. Proc. 18:589.
19. Dent, P. B., R. D A. Peterson, and R.A. Good. 1965. A defect in cellular immunity during the incubation period of passage A leukemia in C3H mice. Proc. Soc. Exp. Biol. Med. 119:869.
20. Dent, P. B. 1972. Immunodepression by oncogenic viruses. Prog. Med. 14:1.
21. Haraguchi, S., R. A. Good, G. J. Cianciolo, R. W. Engelman, and N. K. Day. 1997. Immunosuppressive retroviral peptides: immunopathological implications for immunosuppressive influences of retroviral infections. J. Leukocyte Biol. 61: 654.
22. Snyderman, R., and G. J. Cianciolo. 1984. Immunosuppressive activity of the retroviral envelop protein p15E and its possible relationship to neoplasia. Immunol. Today 5:240.
23. Cianciolo, G. J., T. D. Copeland, S. Oroszlan, and R. Snyderman. 1985. Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins. Science 230:453.
24. Oostendorp, R. A. J., W. M. M. Schaaper, J. Post, M. E. von Blomberg, R. H. Meloen, and R. J. Scheper. 1992. Suppression of lymphocyte proliferation by a retroviral p15E-derived hexapeptide. Eur. J. Immunol. 22:1505.
25. Oostendorp, R. A. J., J. Post, M. E. von Blomberg, and R. J. Scheper. 1992. Immunosuppression by Retrovirus-Derived Peptides. Vrije Universiteit, Amsterdam, The Netherlands.
26. Haraguchi, S., R. A. Good, and N. K. Day. 1995. Immunosuppressive retroviral peptides: cAMP and cytokine patterns, Immunol. Today 16:595.
27. Steven, N. M., A. M. Leese, N. Annals, S. Lee, and A. B. Rickinson. 1996. Epitope focussing in the primary cytotoxic T-cell response to Epstein-Barr virus and its relationship to T cell memory. J. Exp. Med 184:1801.
28. + memory T cells. J. Exp. Med. 186:859.
29. Scotet, E., J. David-Ameline, M. A. Peyrat, A. Moreau-Aubry, D. Pinczon, A. Lim, J. Even, G. Semana, J. M. Berthelot, R. Breathnach, et al. 1996. T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis. J. Exp. Med. 184:1791.
30. Raposo, G., H. W. Nijman, W. Stoorvogel, R. Lijendekker, C. V. Harding, C. J. M. Melief, and H. J. Geuze. 1996. B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 183:1161.
31. Brink, A. A. T. P., J. J. Oudejans, A. J. C. van den Brule, Ph. M. Kluin, A. Horstman, G. J. Ossenkoppele, P. van Heerde, N. M. Jiwa, and C. J. L. M. Meijer. 1998. Low p53 and high bcl-2 expression in Reed-Sternberg cells predicts poor clinical outcome for Hodgkin's disease: involvement of apoptosis resistance? Mod. Pathol. 11:376.
32. + T lymphocytes. Int. J. Cancer 62:5.
33. Herbst, H., H. D. Foss, J. Samol, I. Araujo, H. Klotzbach, H. Krause, A. Agathanggelou, G. Niedobitek, and H. Stein. 1996. Frequent expression of interleukin-10 by Epstein-Barr virus-harboring tumor cells of Hodgkin' s disease. Blood 87:2918.
34. Nakagomi, H., R. Dolcetti, M. T. Bejarano, P. Pisa, R. Kiessling, and M. G. Masucci. 1994. The Epstein-Barr virus latent membrane protein (LMP1) induces interleukin-10 production in Burkitt lymphoma lines. Int. J. Cancer 57: 240.
35. Clausse, B., K. Fizazi, V. Walczak, C. Tetaud, J. Wiels, T. Tursz, and P. Busson. 1997. High concentrations of the EBV latent membrane protein 1 in glycosphingolipid-rich complexes from both epithelial and lymphoid cells. Virology 228: 285.
36. Ardila-Osorio, H., B. Clausse, Z. Mishal, J. Wiels. T. Tursz, and P. Busson. 1999. Evidence of LMP1-TRAF3 interactions in glycosphingolipid-rich complexes of lymphoblastoid and nasopharyngeal carcinoma cells. Int. J. Cancer 81:645.